NEPHROS, INC. (NEPH) Operating Margin
- Operating margin · 12 months: Value 7.92%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 7.92% | Operating income / revenue. Period ending 2026-06-30. $1.64M ÷ $20.72M × 100 ≈ 7.92% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 1.64M USD | Operating Income (Loss) |
| Revenue | 20.72M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 8.03M USD | Cost of Goods and Services Sold |
| Research and development | 1.45M USD | Research and Development Expense |
| Selling, general and administration | 9.48M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.64M | $20.72M | $8.03M | $1.45M | $9.48M | 7.92% |
| 2026-03-31 | $677.00K | $19.12M | $7.66M | $1.39M | $9.27M | 3.54% |
| 2025-12-31 | $1.15M | $18.79M | $7.16M | $1.34M | $9.00M | 6.10% |
| 2025-09-30 | $1.45M | $17.93M | $6.59M | $1.20M | $8.56M | 8.06% |
| 2025-06-30 | $1.34M | $16.68M | $6.11M | $1.05M | $8.05M | 8.01% |
| 2025-03-31 | $772.00K | $15.52M | $5.83M | $989.00K | $7.79M | 4.98% |
| 2024-12-31 | $6.00K | $14.16M | $5.44M | $906.00K | $7.68M | 0.04% |
| 2024-09-30 | $-960.00K | $13.55M | $5.28M | $862.00K | $8.21M | -7.09% |
| 2024-06-30 | $-1.37M | $13.77M | $5.46M | $879.00K | $8.63M | -9.94% |
| 2024-03-31 | $-1.49M | $14.06M | $5.58M | $846.00K | $8.93M | -10.57% |
| 2023-12-31 | $-1.59M | $14.24M | $5.83M | $873.00K | $8.91M | -11.19% |
| 2023-09-30 | $-1.64M | $13.54M | $5.65M | $1.02M | $8.29M | -12.09% |
| 2023-06-30 | $-2.71M | $12.21M | $5.74M | $1.07M | $7.89M | -22.24% |
| 2023-03-31 | $-3.09M | $11.51M | $5.72M | $1.12M | $7.54M | -26.87% |
| 2022-12-31 | $-4.33M | $9.97M | $5.24M | $1.25M | $7.59M | -43.46% |
| 2022-09-30 | $-5.45M | $10.32M | $5.51M | $1.89M | $8.14M | -52.79% |
| 2022-06-30 | $-5.36M | $10.47M | $5.21M | $2.13M | $8.28M | -51.15% |
| 2022-03-31 | $-5.27M | $9.86M | $4.67M | $2.19M | $8.06M | -53.48% |
| 2021-12-31 | $-4.33M | $10.40M | $4.66M | $2.17M | $7.71M | -41.67% |
| 2021-09-30 | $-4.02M | $9.97M | $4.40M | $2.28M | $7.11M | -40.27% |
| 2021-06-30 | $-3.79M | $9.46M | $4.07M | $2.40M | $6.76M | -40.03% |
| 2021-03-31 | $-4.27M | $8.77M | $3.76M | $2.75M | $6.51M | -48.67% |
| 2020-12-31 | $-4.28M | $8.56M | $3.65M | $2.76M | $6.47M | -49.94% |
| 2020-09-30 | $-3.85M | $9.39M | $3.88M | $2.91M | $6.53M | -40.98% |
| 2020-06-30 | $-3.61M | $10.36M | $4.26M | $2.94M | $6.77M | -34.84% |
| 2020-03-31 | $-2.88M | $11.09M | $4.52M | $2.90M | $6.57M | -25.96% |
| 2019-12-31 | $-3.15M | $10.33M | $4.25M | $3.09M | $6.12M | -30.53% |
| 2019-09-30 | $-3.59M | $8.79M | $3.65M | (m) | $5.79M | -40.90% |
| 2019-06-30 | $-3.41M | $7.41M | $3.14M | (m) | $5.07M | -45.98% |
| 2019-03-31 | $-3.19M | $6.47M | $2.74M | (m) | $4.76M | -49.36% |
| 2018-12-31 | $-3.02M | $5.69M | $2.48M | (m) | $4.52M | -53.03% |
| 2018-09-30 | $-2.69M | $5.38M | (m) | (m) | $4.31M | -50.05% |
| 2018-06-30 | $-2.70M | $4.57M | (m) | (m) | $4.00M | -59.05% |
| 2018-03-31 | $-2.74M | $4.06M | (m) | (m) | $3.79M | -67.59% |
| 2017-12-31 | $-2.23M | $3.81M | (m) | (m) | $3.30M | -58.44% |
| 2017-09-30 | $-2.43M | $3.25M | (m) | (m) | $3.02M | -74.74% |
| 2017-06-30 | $-2.55M | $2.81M | (m) | (m) | $2.92M | -90.62% |
| 2017-03-31 | $-2.67M | $2.46M | (m) | (m) | $2.85M | -108.28% |
| 2016-12-31 | $-2.87M | $2.32M | (m) | (m) | $2.85M | -123.66% |
| 2016-09-30 | $-3.20M | $2.09M | (m) | (m) | $3.13M | -153.21% |
| 2016-06-30 | $-3.65M | $1.93M | (m) | (m) | $3.45M | -188.87% |
| 2016-03-31 | $-3.42M | $1.99M | (m) | (m) | $3.38M | -171.91% |
| 2015-12-31 | $-3.42M | $1.94M | (m) | (m) | $3.44M | -175.98% |
| 2015-09-30 | $-3.27M | $1.77M | (m) | (m) | $3.24M | -184.51% |
| 2015-06-30 | $-2.87M | $1.95M | (m) | (m) | $3.04M | -147.51% |
| 2015-03-31 | $-2.91M | $1.82M | (m) | (m) | $3.00M | -160.14% |
| 2014-12-31 | $-2.67M | $1.75M | (m) | (m) | $2.87M | -152.69% |
| 2014-09-30 | $-2.95M | $1.63M | (m) | (m) | $2.99M | -180.82% |
| 2014-06-30 | $-2.88M | $1.56M | (m) | (m) | $2.81M | -184.67% |
| 2014-03-31 | $-2.87M | $1.69M | (m) | (m) | $2.77M | -169.68% |
| 2013-12-31 | $-3.32M | $1.74M | (m) | (m) | $3.11M | -190.63% |
| 2013-09-30 | $-3.56M | $1.88M | (m) | (m) | $3.55M | -189.21% |
| 2013-06-30 | $-3.81M | $2.07M | (m) | (m) | $3.98M | -183.99% |
| 2013-03-31 | $-3.99M | $1.79M | (m) | (m) | $4.16M | -222.23% |
| 2012-12-31 | $-3.33M | $1.81M | (m) | (m) | $3.62M | -184.45% |
| 2012-09-30 | $-2.86M | $1.93M | (m) | (m) | $3.27M | -148.44% |
| 2012-06-30 | $-2.43M | $1.73M | (m) | (m) | $2.84M | -140.61% |
| 2012-03-31 | $-2.22M | $2.07M | (m) | (m) | $2.63M | -107.45% |
| 2011-12-31 | $-2.31M | $2.21M | (m) | (m) | $2.64M | -104.34% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-1.89M | $2.94M | (m) | (m) | $2.52M | -64.30% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |